FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.05-5485fje.
This Article
Right arrow Summary
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.05-5485fjev1
20/11/1880    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maragathavally, K. J.
Right arrow Articles by Coates, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maragathavally, K. J.
Right arrow Articles by Coates, C. J.
(The FASEB Journal. 2006;20:1880-1882.)
© 2006 FASEB

Chimeric Mos1 and piggyBac transposases result in site-directed integration

K. J. Maragathavally, J. M. Kaminski* and C. J. Coates1

Department of Entomology, Texas A&M University, College Station, Texas, USA; and
* Department of Radiology, Medical College of Georgia, Augusta, Georgia, USA

1Correspondence: Department of Entomology, Texas A&M University, College Station, Texas, USA. E-mail: ccoates{at}tamu.edu

ABSTRACT

Genetic transformation systems based on Mos1 and piggyBac transposable elements are used to achieve stable chromosomal integration. However, integration sites are randomly distributed in the genome and transgene expression can be influenced by position effects. We developed a novel technology that utilizes chimeric transposases to direct integration into specific sites on a target DNA molecule. The Gal4 DNA binding domain was fused to the NH2 terminus of the Mos1 and piggyBac transposases and a target plasmid was created that contained upstream activating sequences (UAS), to which the Gal4 DBD binds with high affinity. The transpositional activity of the Gal4-Mos1 transposase was 12.7-fold higher compared to controls where the Gal4-UAS interaction was absent and 96% of the recovered transposition products were identical, with integration occurring at the same TA site. In a parallel experiment, a Gal4-piggyBac transposase resulted in an 11.6-fold increase in transpositional activity compared to controls, with 67% of the integrations occurring at a single TTAA site. This technology has the potential to minimize nonspecific integration events that may result in insertional mutagenesis and reduced fitness. Site-directed integration will be advantageous to the manipulation of genomes, study of gene function, and for the development of gene therapy techniques.—Maragathavally, K. J., Kaminski, J. M., Coates, C. J. Chimeric Mos1 and piggyBac transposases result in site-directed integration.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
N. Sharma, B. Moldt, T. Dalsgaard, T. G. Jensen, and J. G. Mikkelsen
Regulated gene insertion by steroid-induced {Phi}C31 integrase
Nucleic Acids Res., June 1, 2008; 36(11): e67 - e67.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. E. Morales, V. H. Mann, K. J. Kines, G. N. Gobert, M. J. Fraser Jr, B. H. Kalinna, J. M. Correnti, E. J. Pearce, and P. J. Brindley
piggyBac transposon mediated transgenesis of the human blood fluke, Schistosoma mansoni
FASEB J, November 1, 2007; 21(13): 3479 - 3489.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. C.-Y. Wu, Y.-J. J. Meir, C. J. Coates, A. M. Handler, P. Pelczar, S. Moisyadi, and J. M. Kaminski
From the Cover: piggyBac is a flexible and highly active transposon as compared to Sleeping Beauty, Tol2, and Mos1 in mammalian cells
PNAS, October 10, 2006; 103(41): 15008 - 15013.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Feschotte
The piggyBac transposon holds promise for human gene therapy
PNAS, October 10, 2006; 103(41): 14981 - 14982.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.